About
About this site
Who publishes this ipamorelin reference, what it does and does not cover, why it sells nothing, and how to report an error in a record or a citation.
By the Ipamorelin Research editorial team · Last reviewed · Scientific review: pending
Short answer
This site is a reference on the published research into ipamorelin. It indexes all 55 records returned by a reproducible PubMed search, every registered clinical trial, and the primary regulatory documents. It sells nothing, links to no seller, and carries no advertising or affiliate links.
What this site is
Ipamorelin is searched for heavily and written about badly. Most of what exists online describes a compound with proven benefits for muscle, fat loss, recovery and ageing. The actual research record is one randomised controlled trial with a null efficacy result, a second trial of 320 patients that was never reported, a single human pharmacodynamic study from 1999, and a preclinical literature whose findings sometimes point in the opposite direction to the claims.
This site exists to make that record easy to check. Every statement is linked to the primary source it came from, every count is computed from the underlying data rather than typed by hand, and every gap is stated as a gap.
What this site is not
- Not medical advice. Nothing here is a recommendation to obtain, use or avoid any substance, and nothing here is a substitute for a qualified clinician.
- Not a shop, and not connected to one. There are no product links, no affiliate relationships, no advertising and no sponsored content. No commercial relationship influences what appears here.
- Not a source of dosing or administration guidance. No dose, schedule, route, preparation method or protocol is published here, for ipamorelin or any other compound. Research doses appear only as descriptions of what a given study did.
- Not complete. It covers what a PubMed search for ipamorelin returns. Research in other languages, unindexed literature, and the unreported 320-patient trial are all outside it.
Who writes it
Pages are written and maintained by the Ipamorelin Research editorial team against the rules on the editorial policy page. The research corpus is assembled by an automated pipeline from PubMed, ClinicalTrials.gov, PubChem and FDA sources, and the classifications and interpretation applied to it are editorial judgements.
No record on this site has yet passed named human scientific review. Every page says “Scientific review: pending” for that reason, and will continue to until a named reviewer signs off, at which point their name will appear on the pages they reviewed. Stating this plainly is part of the point: a site about weak evidence should not overstate its own.
How the research is handled
The search strategy, verification steps, classification scheme, evidence grades and editorial workflow are documented in full on the methodology page, including the cases where a judgement was close and the reasoning behind it.
Reporting an error
If a citation is wrong, a study is mischaracterised, a regulatory fact is out of date, or a record is missing, that is worth knowing about. Corrections are made to the underlying data, which rebuilds every page that uses it, and material factual corrections are noted on the affected page.
A contact address has not yet been published for this site. Until it is, the primary sources behind every claim are linked directly from each page and from the reference list at the foot of it, so any statement here can be checked against the record it came from without going through us.
Dates
The research corpus was last verified against its primary sources on 2026-11-11. Regulatory records were last checked on 2026-11-11. Each page carries its own last-reviewed date in the header.